Anterior Temporal Epilepsy, Anterior Temporal Lobectomy, Face Perception
Conditions
Brief summary
The purpose is to evaluate neuropsychological effects of anterior temporal epilepsy in face perception by comparison of performances of epileptic patients and control individuals, sex-, age- and socio-educational level-matched. Secondary purposes are to prospectively evaluate neuropsychological impact of anterior temporal lobectomy performed for surgical treatment of anterior temporal epilepsy on face perception (exploratory study).
Interventions
In patients with anterior temporal epilepsy, at 6 to 12 months after inclusion, depending on surgery decision taken after pre-surgery conventional intercritical assessment
Sponsors
Study design
Eligibility
Inclusion criteria
ALL: * Informed consent * Affiliation to social security * Preliminary medical examination PATIENTS WITH EPILEPSY: * Symptomatic drug-resistant anterior temporal epilepsy (confirmed with video-electroencephalography and magnetic resonance imaging and if necessary intracerebral SEEG exploration) * Patient needing anterior temporal lobectomy and undergoing pre-surgery conventional intercritical assessment for surgery decision * Nonverbal IQ ≥ 70 (WAIS-IV) * At least 6 successful VOSP tests (perception test)
Exclusion criteria
ALL: * persons under legal protection or incapable to consent * Persons deprived of liberty by juridical or administrative decision PATIENTS WITH EPILEPSY: \- Sever visual disorders of neurological or ophthalmological origin CONTROL INDIVIDUALS: * Psychiatric or neurological disorders * Important ophthalmological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scores obtained with Benton test by patients with anterior temporal epilepsy and matched control individuals | day 0 |
Secondary
| Measure | Time frame |
|---|---|
| Change of scores obtained with Benton test by epilepsy patients before and after lobectomy and control individuals (only patients having undergone anterior temporal lobectomy and matched control individuals) | day 0 and after 12 to 18 months |
Countries
France